Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 94,841 | 163,030 | 205,398 | 126,824 | 153,192 |
| Marketable Securities | 11,703 | 18,311 | 27,605 | 68,971 | 94,809 |
| TOTAL | $116,081 | $194,764 | $247,513 | $209,580 | $263,250 |
| Non-Current Assets | |||||
| PPE Net | 24,306 | 22,985 | 19,484 | 19,520 | 19,066 |
| Investments And Advances | 1,401 | 1,401 | 1,401 | 1,401 | 1,401 |
| Other Non-Current Assets | 128,406 | 129,634 | 43,470 | 42,695 | 36,172 |
| TOTAL | $154,113 | $154,020 | $64,355 | $63,616 | $56,639 |
| Total Assets | $270,194 | $348,784 | $311,868 | $273,196 | $319,889 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,297 | 17,440 | 10,449 | 13,992 | 6,791 |
| Accrued Expenses | 44,361 | 59,840 | 59,169 | 56,889 | 48,278 |
| TOTAL | $63,818 | $85,596 | $81,819 | $89,037 | $82,359 |
| Non-Current Liabilities | |||||
| Long Term Debt | 51,234 | 50,591 | 50,857 | 50,632 | 50,437 |
| Deferred Revenues | 2,376 | 4,259 | 4,868 | 11,098 | 20,441 |
| Other Non-Current Liabilities | 108,178 | 109,384 | 18,811 | 20,459 | 24,254 |
| TOTAL | $254,247 | $252,405 | $162,464 | $161,101 | $156,574 |
| Total Liabilities | $318,065 | $338,001 | $244,283 | $250,138 | $238,933 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,395 | 6,304 | 6,230 | 6,204 | 4,612 |
| Common Shares | 127 | 125 | 124 | 92 | 92 |
| Retained earnings | -935,685 | -864,511 | -795,715 | -735,713 | -670,978 |
| Other shareholders' equity | 2 | -12 | -118 | -256 | -215 |
| TOTAL | $-47,871 | $10,783 | $67,585 | $23,058 | $80,956 |
| Total Liabilities And Equity | $270,194 | $348,784 | $311,868 | $273,196 | $319,889 |